Clinical Trial Update: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chemotherapy with or without trastuzumab in women with metastatic breast cancer; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Cancer, Stage IV Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2011-11-23